Navigation Links
Blood Clots in Legs, Lungs Predispose Patients to Repeat Episodes
Date:2/25/2008

They're at risk for new blockages within 3 years, study finds

MONDAY, Feb. 25 (HealthDay News) -- People who develop a blood clot in their legs (deep vein thrombosis) or in their lungs (pulmonary embolism) are at risk of developing another blood clot within three years, a new study suggests.

Deep vein thrombosis and pulmonary embolism are known collectively as venous thromboembolism.

Researchers looked at 1,691 people, average age 65, in Worcester, Mass., diagnosed with pulmonary embolism (549) and isolated deep vein thrombosis (1,142) in 1999, 2001 or 2003. During the three-year study, 31 (5.7 percent) of the pulmonary embolism patients had a recurrent clot in the lung, 75 (13.7 percent) had a recurrence of either type of venous thromboemolism, and 82 (14.9 percent) had a major bleeding episode (one that required blood transfusion).

Among the 1,142 patients with isolated deep vein thrombosis, 64 (5.6 percent) developed a pulmonary embolism, 217 (19 percent) had recurrent venous thromboembolism, and 146 (12.8 percent) had a major bleeding episode.

Patients with pulmonary embolism were more likely than those with deep vein thrombosis to die after one month (13 percent vs. 5.4 percent), one year (26 percent vs. 20.3 percent), and three years (35.3 percent vs. 29.6 percent).

"Patients whose course was complicated by major bleeding were more likely to experience recurrent venous thromboemolism or to die at three years than those without these complications," wrote Dr. Frederick A. Spencer, of McMaster University Medical Center in Hamilton, Ontario, Canada.

"Patients who presented with pulmonary embolism had similar rates of subsequent pulmonary embolism or recurrent venous thrombosis compared with patients with isolated deep vein thrombosis," the study authors noted.

"However, rates of recurrent venous thromboembolism and major bleeding after deep vein thrombosis and pulmonary embolism remain unacceptably high in the community setting. Efforts are needed to identify patients most at risk for venous thrombosis-associated complications and to develop better anti-coagulation strategies conducive to long-term use in the community setting," they concluded.

The study was published in the Feb. 25 issue of the Archives of Internal Medicine.

More information

The U.S. National Heart, Lung, and Blood Institute has more about deep vein thrombosis.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Feb. 25, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mechanism of blood clot elasticity revealed in high definition
2. Indiana Blood Center Signs BIO-key(R) Contract
3. Current Blood Sugar Control Test Results Inaccurate
4. Another way to grow blood vessels
5. Study identifies another strategy for normalizing tumor blood supply
6. Standard test for blood sugar control not accurate in diabetic dialysis patients
7. Mix-Up Behind FDAs Failure to Inspect China Blood-Thinner Plant
8. UNT Health Science Center and The Center for Cancer and Blood Disorders Collaborate on New Institute for Cancer and Blood Disorders
9. Blood pressure drug may have added benefit
10. Two Laptop Computers Missing From Lifebloods Main Office
11. Airplane Noise Boosts Blood Pressure Even During Sleep
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Clots in Legs, Lungs Predispose Patients to Repeat Episodes
(Date:3/28/2017)... ... ... women, getting birth control isn’t as easy as it should be. In fact, millions of ... health care facility or a pharmacy within 60 minutes of where they live. This is ... who are faced with health or personal issues that leave them homebound. To help facilitate ...
(Date:3/28/2017)... , ... March 29, 2017 , ... ... leading thyroid pharmacist Dr. Isabella Wentz, Pharm.D., FASCP. The program was recently launched ... besides answering common questions regarding thyroid function. , Dr. Izabella Wentz is ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... by physicians, announced today the launch of a free, public-facing tool for analyzing ... Analyzer (VCA) was developed to provide comparative information to patients, providers, insurers and ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Radiology Business ... has begun to serve as its new executive director. Mr. Still was selected through ... Committee. , “Bob, as he is known to our members, has been a ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists in ... quality care can be limited while the desire to conquer breakouts and eliminate skincare ... care for every customer online, today released its inaugural survey on the State of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017  Medeon Biodesign, Inc., a ... to announce that the Company led and successfully ... Inc., a San Jose, CA ... orthopedic extremity applications.  The orthopedic ... due to procedure volume growth, lifestyle influences and ...
(Date:3/28/2017)... March 28, 2017  Rosen Law Firm, a global ... class action lawsuit on behalf of purchasers of Kitov ... pursuant and/or traceable to Kitov,s initial public offering on ... the open market from November 20, 2015 through February ... lawsuit seeks to recover damages for Kitov investors under ...
(Date:3/28/2017)... , March 28, 2017 ... Pharmaceutical Marketing Strategies: Digital as a Key Component ... the changing pharmaceutical marketing landscape in the digital ... new technologies to provide medical advancements, it has ... marketing efforts, mostly relying on traditional channels and ...
Breaking Medicine Technology: